Loading...

Sourcebio International Plc

SBI.LLSE
Healthcare
Medical - Diagnostics & Research
£115.00
£5.00(4.55%)

Sourcebio International Plc (SBI.L) Company Profile & Overview

Explore Sourcebio International Plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sourcebio International Plc (SBI.L) Company Profile & Overview

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOJay Charles LeCoque

Contact Information

44 11 5973 9012
1 Orchard Place, Nottingham, NG8 6PX

Company Facts

339 Employees
IPO DateOct 29, 2020
CountryGB

Frequently Asked Questions

;